Socomed Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Socomed Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $25.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Socomed Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $25.0M Trade | TransData Nexus

Socomed Pharma Private Limited

Indian Pharmaceutical Exporter · Respiratory & OTC Specialist · $25.0M Total Trade · DGFT Verified

Socomed Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $25.0M across 6 products in 4 therapeutic categories. Based on 1,131 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Caffeine ($9.6M), Paracetamol ($6.9M), Diclofenac ($3.2M).

Socomed Pharma Private Limited — Export Portfolio & Destination Treemap

Socomed Pharma Private Limited pharmaceutical export portfolio — 6 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Socomed Pharma Private Limited? — Company Overview & Market Position

Socomed Pharma Private Limited, incorporated on April 24, 2008, is a private limited company based in Mumbai, Maharashtra, India. The company is classified under the Corporate Identification Number (CIN) U24233MH2008PTC181516 and is registered with the Registrar of Companies, Mumbai. Its authorized share capital is ₹5,000,000, with a paid-up capital of ₹4,861,500. The registered office is located at ORM B-Wing, Unit No 112, Upper Gr. Survey No. 169, Aarey Milk Colony, Near Unit No. 26, Goregaon (E), Mumbai, Maharashtra 400065, India.

Socomed Pharma specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company has a workforce of approximately 30 employees as of October 11, 2025. The official website is www.socomedpharma.com.

What Does Socomed Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Caffeine$9.6M 2Paracetamol

Product Portfolio — Top 6 by Export Value

Socomed Pharma Private Limited exports 6 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Caffeine	Respiratory & OTC	$9.6M	441	8.9%	2
2	Paracetamol	Analgesics & Antipyretics	$6.9M	244	1.9%	9
3	Diclofenac	Analgesics & Antipyretics	$3.2M	150	0.9%	15
4	Phenylephrine	Respiratory & OTC	$2.7M	149	3.1%	5
5	Chlorpheniramine	Antihistamines & Allergy	$2.4M	125	5.2%	4
6	Theophylline	Respiratory	$281.1K	22	1.8%	11

Socomed Pharma Private Limited exports 6 pharmaceutical products across 4 therapeutic categories with a total export value of $25.0M. The top category is Respiratory & OTC (49.0% of portfolio), followed by Analgesics & Antipyretics (40.2%), indicating a concentrated portfolio with the top 5 products accounting for 98.9% of total export value.

Socomed Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Socomed Pharma operates manufacturing facilities in Mumbai, Maharashtra, India. The company specializes in producing a range of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding the capacities and certifications of these facilities are not publicly disclosed.

3Key Leadership

The company's board of directors includes:

Aasif Amirkhan Dange
Director since December 13, 2011.

Bakhtawar Mairaj Aasif Dange
Director since October 1, 2021.

Specific information regarding the CEO, CFO, and other key executives is not publicly available.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Socomed Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Socomed Pharma's presence in regulated markets such as the United States, European Union, United Kingdom, Australia, and Japan is not publicly documented. The company has not disclosed any regulatory filings, approvals, or market access statuses in these regions. This lack of information suggests that Socomed Pharma may not have significant market penetration in these regulated markets.

2Emerging Markets

Socomed Pharma's activities in emerging markets, including Africa, Latin America, and Southeast Asia, are not publicly detailed. The company has not disclosed any information regarding WHO prequalification or other certifications that would enable access to these markets. This absence of information indicates that Socomed Pharma may not have established a significant presence in these regions.

3Geographic Strategy

Socomed Pharma's export data indicates a concentration in specific therapeutic categories, with 49.0% of exports in Respiratory & OTC, 40.2% in Analgesics & Antipyretics, and 9.6% in Antihistamines & Allergy. The company's top five products—Caffeine, Paracetamol, Diclofenac, Phenylephrine, and Chlorpheniramine—account for 98.9% of its total export value. This high portfolio concentration suggests a focused geographic strategy, potentially limiting exposure to market diversification risks.

Socomed Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Socomed Pharma's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. The company has not disclosed any information regarding its status with the U.S. Food and Drug Administration (FDA), indicating a lack of market presence or regulatory approvals in the United States.

2WHO & EU GMP

Socomed Pharma has not publicly disclosed any certifications such as WHO prequalification or EU Good Manufacturing Practice (GMP) certificates. The absence of this information suggests that the company may not have obtained these certifications, which are often required for market access in certain regions.

3CDSCO & Indian Regulatory

Socomed Pharma holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) in India. The company has also obtained approvals from state drug controllers and export No Objection Certificates (NOCs), facilitating its export activities. Specific details regarding these licenses and approvals are not publicly disclosed.

Socomed Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Socomed Pharma operates in the competitive pharmaceutical industry, focusing on finished pharmaceutical formulations. While specific competitors are not identified, the company's export data indicates a strong presence in the Respiratory & OTC and Analgesics & Antipyretics categories. The high concentration of exports in a few products suggests that Socomed Pharma may face competition from other manufacturers specializing in these therapeutic areas.

2Key Differentiators

Socomed Pharma's key differentiators include its specialization in finished pharmaceutical formulations and a focused product portfolio. The company's emphasis on specific therapeutic categories may allow for expertise and efficiency in production. However, the high concentration in a few products could also pose risks related to market fluctuations and demand variability.

3Strategic Position

Socomed Pharma's current strategic direction appears to be focused on manufacturing and exporting finished pharmaceutical formulations, particularly in the Respiratory & OTC and Analgesics & Antipyretics categories. The company's future outlook may involve expanding its product portfolio, obtaining additional regulatory certifications, and exploring new markets to diversify its revenue streams and reduce concentration risks.

Buyer Due Diligence Brief — Evaluating Socomed Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Socomed Pharma has demonstrated a consistent track record in manufacturing and exporting pharmaceutical products, with a total export value of $25.0 million USD and 1,131 shipments across six products. The company's reliability is indicated by its established presence in specific therapeutic categories and a focused product portfolio. However, the high concentration in a few products suggests that Socomed Pharma may need to diversify its offerings to mitigate potential risks associated with market demand fluctuations.

2Certifications to Verify

Importers should verify the following certifications when considering Socomed Pharma as a supplier:

FDA Facility Registration: To confirm compliance with U.S. regulations. Verification can be done through the FDA's official website.

WHO-GMP Certification: To ensure adherence to World Health Organization standards. Verification can be done through the WHO's official website.

Frequently Asked Questions — Socomed Pharma Private Limited

How many pharmaceutical products does Socomed Pharma Private Limited export from India?

Socomed Pharma Private Limited exports 6 pharmaceutical products across 4 therapeutic categories. The top exports are Caffeine ($9.6M), Paracetamol ($6.9M), Diclofenac ($3.2M), Phenylephrine ($2.7M), Chlorpheniramine ($2.4M). Total export value is $25.0M.

What is Socomed Pharma Private Limited's total pharmaceutical export value?

Socomed Pharma Private Limited's total pharmaceutical export value is $25.0M, based on 1,131 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Socomed Pharma Private Limited cover?

Socomed Pharma Private Limited exports across 4 therapeutic categories. The largest are Respiratory & OTC (49.0%, 2 products), Analgesics & Antipyretics (40.2%, 2 products), Antihistamines & Allergy (9.6%, 1 products).

Get Full Socomed Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.